Kathleen Orloski, DVM, MS Diplomate, ACVPM, Epidemiology Specialty USDA, APHIS, Veterinary Services TB Eradication Program April 5-6, 2011.

Slides:



Advertisements
Similar presentations
Mortality Among a Tuberculosis Outbreak Los Angeles County, 2007–2013 Brian Baker, MD Amit Chitnis, MD MPH Leslie Henry, BSN RN PHN 48th CTCA Educational.
Advertisements

Outbreak of Mycobacterium tuberculosis Among Employees of an Elephant Refuge Rendi Murphree, PhD CDR, USPHS Tennessee Department of Health EIS Field Assignments.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
Lessons from “Mycobacterium-related” Elephant necropsy cases Scott P. Terrell, DVM, DACVP.
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2013 Living (Prevalence)
Wisconsin HIV/AIDS Surveillance Annual Review: Slide Set New diagnoses, prevalent cases, and deaths through December 2014 April 2015 P Wisconsin.
Epidemiology of HIV-2 infection in the U.S, Lata Kumar MS, MPH Richard Selik MD Division of HIV/AIDS Prevention National Center for HIV/AIDS,
Is Nucleic Acid Testing for Organ Donors the ‘Right’ Choice? Reference: Humara A, Morrisb M, Blumbergc R, et al. Nucleic acid testing (NAT) of organ donors:
Robert W. Wills, DVM, PhD Diplomate ACVPM (Epidemiology) Pathobiology and Population Medicine College of Veterinary Medicine Mississippi State University.
Quarantines and Eradication Programs 4-H Veterinary Science Extension Veterinary Medicine Texas AgriLife Extension Service College of Veterinary Medicine.
North Dakota Department of Health TB Symposium North Dakota Tuberculosis Update.
Inputs to a case-based HIV surveillance system. Objectives  Review HIV case definitions  Understand clinical and immunologic staging  Identify the.
Serological Testing: ElephantTB STAT-PAK, MAPIA, and DPP VetTB
Use of Network Analysis During a Tuberculosis Investigation Outbreak Investigation Section Surveillance and Epidemiology Branch Division of Tuberculosis.
HIV & AIDS Cases in Alameda County Presentation to the CCPC August 24, 2011 Elaine Bautista & Alex Marr.
Vital & Health Statistics
Multiple Choice Questions for discussion. Part 2
DEPARTMENT OF HEALTH RESEARCH INSTITUTE FOR TROPICAL MEDICINE Ebola Reston in the Philippines Catalino S. Demetria, DVM.
Cardiovascular Disease in Women Module I: Epidemiology.
Development of an oral vaccine against tuberculosis for use in badgers (Meles meles) Dr Eamonn Gormley, UCD Dublin.
Surveillance Plan for Bison Yellowstone National Park.
Surveillance, Epidemiology, and Tracing Surveillance Part 1: The Surveillance Plan Adapted from the FAD PReP/NAHEMS Guidelines: Surveillance, Epidemiology,
Aujeszky-disease.
The role of wild deer as a temporal vector of bovine tuberculosis (Tb) Mandy Barron, Graham Nugent Landcare Research, Lincoln.
Surveillance, Epidemiology, and Tracing Epidemiology Part 1: Principles of Epidemiology Adapted from the FAD PReP/NAHEMS Guidelines: Surveillance, Epidemiology,
Epidemiology With Respect to the Dynamics of Infectious Diseases Huaizhi Chen.
Rendi Murphree, PhD CDR, USPHS CDC Epidemic Intelligence Service Officer Tennessee Department of Health Communicable and Environmental Disease Services.
Quarantine and Movement Control Zones, Areas, and Premises Adapted from the FAD PReP/NAHEMS Guidelines: Quarantine and Movement Control (2014)
Quarterly HIV/AIDS Analysis for Michigan January 1, 2008 Michigan Department of Community Health HIV/STD/Viral Hepatitis and TB Epidemiology Section Division.
Decline in reported GC morbidity in NYC Preeti Pathela
Infectious Disease Epidemiology Surveillance. 9/22/00ANN JOLLY 2 Definition n “Ongoing systematic collection, analysis, and interpretation of health data.
Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2012 Living.
HIV Disease and Hepatitis C Virus (HCV) Co-Infection – Florida, 2011 HIV/AIDS & Hepatitis Program - Surveillance Section HIV Disease data from 1981 through.
A GIS Approach to Staphylococcus Associated Mortality in Texas in 2005 By Samuel F. Barker, MT School of Rural Public Health Texas A&M Health Science Center.
CDC Guidelines for Use of QuantiFERON ® -TB Gold Test Philip LoBue, MD Centers for Disease Control and Prevention Division of Tuberculosis Elimination.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Surveillance During Animal Disease Emergencies Overview.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia.
California Update : TB Epidemiology and Indicators CTCA October 22, 2010 Jennifer Flood MD MPH Chief, Surveillance and Epidemiology Tuberculosis Control.
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2014 Living (Prevalence)
EVALUATING u After retrieving the literature, you have to evaluate or critically appraise the evidence for its validity and applicability to your patient.
BSE: World update FDA TSE Advisory Committee Gaithersburg, MD September 18, 2006 Lisa A. Ferguson, DVM Senior Staff Veterinarian USDA, APHIS, Veterinary.
Country report for “Peste des Petits Ruminants(PPR).” Dr. Yousef S N S SH Al Azemi Head, Epidemiology & Zoonosis, Animal Health Department Public Authority.
The people of Zimbabwe. Population Facts Population 11,350,111 (July 2008 est.) 12,576,742 (July, 2003 est.) 11,342,521 (July 2000 est.) Estimates for.
Surveillance, Epidemiology, and Tracing Epidemiology Part 2: Epidemiology in an FAD Outbreak Adapted from the FAD PReP/NAHEMS Guidelines: Surveillance,
Dr. Janet Payeur, USDA, APHIS, VS, NVSL Dr. Janet Payeur, USDA, APHIS, VS, NVSL Dr. Ray Waters, NADC, ARS Dr. Ray Waters, NADC, ARS Dr. Kathy Orloski,
Public Health Perspective on SARS Diagnostics Stephen M. Ostroff Deputy Director National Center for Infectious Diseases, CDC.
III. Measures of Morbidity: Morbid means disease. Morbidity is an important part of community health. It gives an idea about disease status in that community.
Comparison of a New ESAT-6/ CFP-10 Peptide-Based Gamma Interferon Assay to Tuberculin Skin Test for Tuberculosis Screening in a Moderate Risk Population.
Diabetes and Obesity Journal Club Carina Signori Endocrinology Fellow
NAAT identified chlamydial infections: Enhanced sensitivity, reduced transmissibility? Presenter: Maria Villarroel, MA Authors: Maria A. Villarroel, MA.
TB in Yorkshire and the Humber Dr Simon Padfield 14 th Sept 2007.
1 Disaster epidemiology Professor Vilius Grabauskas Kaunas University of Medicine, Kaunas, Lithuania NATO supported advanced research workshop, Kaunas,
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Community-wide outbreak of hepatitis A in Latvia in 2008 Jurijs Perevoščikovs Head, Department of Epidemiological Surveillance of Infectious Diseases State.
Where Has All the Pertussis Gone? Pertussis Trends from and the Potential Early Impact of Tdap Vaccination National Immunization Conference Dallas,
Depart. of Pulmonology 백승숙. More than 80% of cases of tuberculosis in the United States –The result of reactivated latent infection –Nearly all these.
Government of Swaziland
Understanding the Transmission Patterns of Mycobacterium bovis
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
Surveillance, Epidemiology, and Tracing
Surveillance, Epidemiology, and Tracing
Disaster epidemiology
Progress in Facilitating National HCV Prevention
Cheng shiming National TB Center in China May,3, 2004
Epidemiological Terms
Communicable Disease Surveillance Centre, London
Using Whole Genome Sequencing Analysis in California
Laura Lane, Epidemiologist
Presentation transcript:

Kathleen Orloski, DVM, MS Diplomate, ACVPM, Epidemiology Specialty USDA, APHIS, Veterinary Services TB Eradication Program April 5-6, 2011

 Methods  Case Definition  Demographic information  Apparent Prevalence  Mortality  Diagnostic Testing  Conclusions  Analysis Strengths and Limitations  Recommendations

 APHIS database for elephants  Population: elephants currently monitored for TB and elephants ever confirmed infected with TB  Sex  Species  Living/Died  Trunk wash (TW)  Serology - Pretreatment  ElephantTB Stat-Pak®, multi-antigen print immunoassay (MAPIA)  Official tests except 4 for which no official tests available  Bacteriology/culture  Case definition for a TB infected elephant  Isolation of Mycobacterium tuberculosis or M. bovis by culture from bodily secretions/excretions or tissue samples

 Information for 480 elephants  405 (84.5%) female  75 (15.6%) male  274 (57.1%) Asian elephants  206 (42.9%) African elephants

 51/480 (10.6%) elephants confirmed with M TB or M. bovis  43/405 (10.6%) female  8/75 (10.6%) male  1-8 new cases per year  Median = 3.0  Mean = 3.2  3/480 (0.6%) new TB cases annually  TB 5.7X more frequent in Asian than African elephants SpeciesM TB Positive Total Elephants Percent Infected African % Asian % Total %

n = 51 elephants, including one elephant with M. bovis in 2000 M. bovis

 There were 4.2 new TB cases per 100,000 people in 2008 in the United States*  At 3.0 new cases per an estimated 450 living elephants, if there were 100,000 elephants, that would equate to approximately  677 cases/100,000 elephants/year  New TB cases are being detected in US elephants at 161X higher rate than in the US human population  677/4.2 = 161 *Centers for Disease Control and Prevention, Morbidity and Mortality Weekly Report, March 20, 2009; 58(10):

 Of the 51 confirmed TB cases  33 (64.7%) have died  Of these  6/6 African elephants died  27/45 Asian elephants died  TB and other disease conditions found at necropsy  Not a true case mortality rate  Further evaluation of comorbidities, age and treatment needed SpeciesDiedTotal Infected Percent Died African % Asian % Total %

 Of the 51 confirmed TB cases  72.1% of females have died  25.0% of males have died  Mortality in females with TB 2.9X higher than in males with TB SexDied Total Infected Percent Died Female % Male2825.0% Total %

Confirmed Infected Elephants

 Trunk wash  Material collected then cultured  Isolation of mycobacterium confirms infection by gold standard  ElephantTB Stat-Pak® – initial serology test  Evaluates for presence of antibodies to M TB bacteria  Multi-antigen print immunoassay – follow-up to Stat-Pak®  Evaluates for presence of antibodies to a larger number of M TB antigens than Stat-Pak®

Test TW Positive or SP Reactive (%) TW Negative or SP Nonreactive (%) Confirmed Infected Elephants* Trunk Wash (TW) 30 (62.5)18 (37.5)48 Stat-Pak (SP) 19 (100.0)019 Stat-Pak / MAPIA 18 (100.0)018** *51 elephants met the case definition - M TB or M. bovis isolated from bodily secretions / excretions or tissue samples. Of the 51 elephants meeting the case definition, 48 have been tested by trunk wash, 19 by Stat-Pak® and 18 by multi-antigen print immunoassay (MAPIA) **MAPIA pending for one case

Test Trunk Wash Positive Trunk Wash Negative Stat-Pak Reactive 181 Stat-Pak Nonreactive 00 *Of 51 elephants that met the case definition of M TB or M. bovis isolated from bodily secretions / excretions or tissue samples; 19 have been tested by both trunk wash and Stat-Pak®.

Elephants not culture positive for M TB or M. bovis

Test SP Reactive or MAPIA pos (%) SP Nonreactive or SP NR and MAPIA neg (%) Total Elephants Not Culture Positive Stat-Pak 77 (20.4)300 (79.6)377* Stat-Pak / MAPIA** 24 (6.4)351** (93.6)375 *Of 429 elephants, 52 not tested by Stat-Pak® **MAPIA results for 77 Stat-Pak reactive samples, 51 were negative. Results excluded for two with suspect results.

 In confirmed infected elephants  Trunk wash testing detected TB in 30/48  37.5% false negative  Stat-Pak only, positive results in 19/19  No false negatives  The balance of the elephant population = 429  Trunk wash negative (~412), or not tested yet (17)  Stat-Pak®/MAPIA, evidence of antibodies to M TB in 24 elephants  Potential for false positives exists  MAPIA may be reducing change of false positives?

 Overall apparent prevalence 10.6%,  Annually 1-8 new cases detected thru surveillance  Median 3.0 new cases per year  TB transmission continuing to occur vs recrudescence in historically exposed individuals  Females and males equally affected  Overall mortality 64.7%; higher in female elephants, African elephants  >80% of US herd is female  Asian elephants 5.7X more likely to be infected with M TB than African elephants

 In confirmed infected elephants, trunk wash (TW) testing has substantial number of false negative results, compared to serology  37.5% vs 0%, TW vs Stat-Pak (SP)  TW detects localized shedding  SP/MAPIA detects systemic antibody production  Serologic testing provides evidence of M TB infection in TW negative elephants

 Strengths  Information on entire population  Superior to sampling portion of population  Limitations  Age, comorbidities, treatment, exposure - not included in analysis  Important in evaluating prevalence, mortality  Limited information for TW negative elephants  Small number of infected African elephants

 Surveillance testing critically important  To enhance case detection and implement mitigations to decrease transmission risks  Follow-up testing of Stat-Pak reactive and MAPIA positive elephants  Develop database standards of information collected for TB infected and TW negative animals  Plan for additional analyses  Epidemiologic studies needed to determine specific risk factors for transmission  Follow guidelines to decrease animal to animal and animal to human transmission risk

Thank you C